FDA Investigator Ana E Morales

Ana E Morales has inspections in 1 countries as of 18 Oct 2023. Ana E Morales has collaborated with a combined 3582 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America
Aaron L Dunbar, Aaron P Wozniak, Adam J Taylor, Adam M True, Alan M Roberts, Alecia L Marson, Alexandra A Carrico, Alois P Provost, Amir Alavi, Amos, Andrew A Leboeuf, Anthony R Petriella, Anthony R Ronga, Antoinette L Chancey, Ashley L Reiber, Audrey Dela Cruz, Boun M Xiong, Bradley J Maunder, Brentley S Collins, Brian D Nicholson, Brian J Mundo, Brian L Szcyubialka, Brian P Emanuel, Brittany A Mckenzie, Brittany N Ross, Bruce, Bruce H Mccullough, Bunce, Carl A Huffman, III, Carrie Ann Plucinski, Catherine M Vanderhoef, Chad J Whitwell, Charlie P Booker, Chase S Baldwin, Christi L Bellmore, Christina A Miller, Christina Chrysogelos, Christopher B Harding, Christopher D Leach, Clotia Cabbey Mensah, Como, Courtney E Hillier, Crystal L Parks, Daniel B Arrecis, Danny Tuntevski, Dariusz Galezowski, Darrell E Luedtke, David J Leray, David M Amy, David Perkins, Dawnna D Brown, Debra I Love, Dell S Moller, Denise L Burosh, Diane M Fresch, Diane T Reindl, Donald W Myrick, Donna K Speer, Edwardstine J Reese, Elias H Wachter, Elizabeth L Holmes, Elizabeth P Mayer, Emilio Campos, Enrico Joset Mangahis, Eric A Breselow, Erin M Miller, Fernando C Martinez, Freed A Sharif, Geneve M Maxwell, Geneve M Parks, Hans T Meyers, Insook Son, Jacob G Lutz, James E Roberts, James P Duggan, James T Karpus, James W Plucinski, Jamie R Thompson, Janis R Armedoriz, Jason F Chancey, Jayne E Holcomb, Jean M Bosenbecker, Jeanne J Chiu, Jeffry A Bernhardt, Jennifer A D'angelo, Jennifer C Johnson, Jennifer Guttuso, Jennifer L Mecher, Jennifer R Johnson, Jerri E Lothrop, Jesse A Vazquez, Jesse P Romenesko, Jessica L Barr, Jessica L Burley, Jocelyn C Turner, Joel D Hustedt, John E Emmert, John M Seale, John N Woodall, Joseph A Morkunas, Joseph D Cooper, Joshua M Adams, Justin R Hays, Karen M Gasperic, Karla J Youngberg, Kathleen M Adams, Kathleen S Tormey, Kathryn G Brown, Kathryn M Mogen, Katy G Brown, Keith C Rindahl, Kelley L Clark, Kia L Copeland, Kimberly Lewandowski Walker, Kimberly W Destromp, Kristen E Szenderski, Larry F Hallberg, Latoya A Griffith, Lauren A Crivellone, Leeterry Moore, Leon R Stratman, Lequita M Mayhew, Leslie D Hintz, Liliya R Robertson, Liliya V Bubiy, Lisa M Lopez, Lisa M Thursam, Logan M Ebeling, Marcia A Worley, Margaret N Persich, Margaret Torres Vazquez, Maria Diaz, Mark G Peterson, Mark I Kaspar, Marlon K Turner, Martha Sullivan Myrick, Martin R Vowell, Mary R Chestolowski, Matthew R Buenconsejo, Melanie C Voges, Michael D Robinson, Michael R Giammanco, Michele L Glendenning, Micmarie Ramos, Nicholas E Boyd, Nicholas P Diorio, Nicole C Shokatz, Nicole J Clausen, Nicole S Williams, Pablo Alcantara, Paola S Barnett, Patrick E Gainer, Patrick J Campbell, Paula P Demichael, Peng Zhou, Peterson, Phung Thien Nguyen, Rafael A Kaup, Randy D Baxter, Raul Alicea, Rebecca L Mullikin, Renee L Anderson, Richard Jay Tucker, RS, Richard W Koller, Robert G Taylor, Robert J Waldorf, Rohn R Robertson, Rosemary A Sexton, Roshni J Patel, Russell K Riley, Ruth Smith, Ryan S Martin, Sandra D Wilson Newby, Sarah A Palmer, Shalonda C Clifford, Shana L Williams, Sinuet P Yashikiramoto, State Agency, Stefen D Mcmillan, Steven A Skaar, Sullan, Susan D Yuscius, Susan W Ciani, Suzanne M Crotty, Tara C Alcazar, Tara M Humfeld, That Q Dang, Theodore N Sietsema, Theresa M Spicer, Thomas L Bellonte, Timothy Brennan, Todd M Stankewicz, Tonnie L Carter, Torrey M Ward, Uruaku A Obasi, Vera M Anderson, Vesa Vuniqi, Wayne D Stowell, William D Sherman, William D Tingley, William G Nelson, William P Fournier, William R Weissinger, Yuriy Solovyov, Zerita White

Ana E Morales's Documents

Publish Date Document Type Title
February, 2021 FDA 483 Primrose Candy Company - Form 483, 2021-02-25
June, 2018 EIR Kerry Inc - EIR, 2018-06-29
December, 2016 FDA 483 Conagra Brands, Inc - Form 483, 2016-12-13
February, 2021 EIR Primrose Candy Company - EIR, 2021-02-25
March, 2022 FDA 483 Abbott Laboratories - Form 483, 2022-03-18
June, 2018 FDA 483 Kerry Inc - Form 483, 2018-06-29
November, 2018 FDA 483 Kerry Inc - Form 483, 2018-11-13
June, 2016 FDA 483 Garden-Fresh Foods, Inc. - Form 483, 2016-06-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more